Cysteine

Cysteine

SCHEMBL95110

N[C@H](CS)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cysteine SCHEMBL29387447 1.00 — —
Cysteine SCHEMBL7898895 1.00 PTGS1 (1.00) —
Cysteine SCHEMBL29965523 1.00 — —
Cysteine SCHEMBL339562 1.00 PTGS1 (1.00) —
Cysteine SCHEMBL5705426 1.00 PTGS1 (1.00) —
Cysteine SCHEMBL5705430 1.00 PTGS1 (1.00) —
Cysteine SCHEMBL1868335 1.00 PTGS1 (1.00) —
Cysteine SCHEMBL4289403 1.00 — —
Cysteine SCHEMBL21110883 1.00 PTGS1 (1.00) —
Cysteine SCHEMBL30607088 1.00 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10435 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12636312-B2 Gold clusters (AuCs), composition and method for treatment of liver cirrhosis WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD. (CN) 2026-05-26 — — US claimed
CN-122080142-A Polypeptide for cancer targeted therapy and corresponding drug/fluorescent dye conjugate thereof — 2026-05-26 — — CN claimed
CN-122076416-A Visible light response type titanium dioxide photocatalyst and preparation method and application thereof — 2026-05-26 — — CN claimed
CN-122074077-A Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy 省卫生服务机构 2026-05-22 — — CN claimed
US-20260139060-A1 METHODS OF PRODUCING HETERODIMERIC ANTIBODIES GENMAB AS (DK) 2026-05-21 — — US claimed
CN-122070294-A Stable vitreous material based on histidine, arginine and glutamic acid amino acids 阵序补丁有限公司 2026-05-19 — — CN claimed
CN-116997543-B D-luciferin and D-luciferin derivatives, precursors of these compounds, and methods for producing these 关东电化工业株式会社 2026-05-15 — — CN claimed
EP-4737477-A2 HEPCIDIN MIMETICS FOR TREATMENT OF HEREDITARY HEMOCHROMATOSIS Protagonist Therapeutics, Inc. (US) 2026-05-06 — — EP claimed
US-20260116921-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES PROTAGONIST THERAPEUTICS INC (US) 2026-04-30 — — US claimed
EP-4731638-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS BicycleTx Limited (GB) 2026-04-29 — — EP claimed
US-4736060-A Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl) ethylamine NIPPON RIKAGAKUYAKUHIN CO., LTD. (JP) 1988-04-05 — — US claimed
US-4725577-A Biologically active lysine containing octapeptides ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 1988-02-16 — — US claimed
US-4650787-A SOMATOSTATIN ANALOG ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND OF NEW ORLEANS, LOUISIANA, THE, 1987-03-17 — — US claimed
EP-0213785-A1 Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl)ethylamine NIPPON RIKAGAKUYAKUHIN CO., LTD. (JP) 1987-03-11 — — EP claimed
EP-0203031-A2 Biologically active lysine containing octapeptides The Administrators of The Tulane University Educational Fund (US) 1986-11-26 — — EP claimed
US-4610963-A QUANTITATIVE ANALYSIS Takara Suzo Co., Ltd. (JP) 1986-09-09 — — US claimed
EP-0024525-B1 Process for the preparation of luciferin and its derivatives Roche Diagnostics GmbH (DE) 1982-06-30 — — EP claimed
US-4337247-A ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-06-29 — — US claimed
US-4302580-A Process for the production of a cephamycin derivative MEIJI SEIKA KAISHA, LTD. (JP) 1981-11-24 — — US claimed
US-4049708-A Fluorodesulfurization of alkyl mercaptans or alkyl dithianes MERCK & CO., INC. (US) 1977-09-20 — — US claimed
Send feedback